Skip to main content
Fig. 4 | ExRNA

Fig. 4

From: Serum microRNAs as novel biomarkers for early prediction of disease severity in patients with acute pancreatitis

Fig. 4

Expression levels of miR-19a, miR-143 and miR-374-5p at different time points during AP. The levels of 3 miRNAs in the SAP and non-SAP (MAP and MSAP) groups were measured on admission and at different time points thereafter, as indicated. a miR-19a in SAP peaked at day 14 and declined at day 21. The trend was similar in the non-SAP group, except for day 2. b miR-143 in SAP peaked at approximately day 7 and declined from day 14. The fluctuation was not obvious in the non-SAP groups. c miR-374-5p showed a trend similar to that of miR-19a and was different between SAP and non-SAP from day 1 to day 3. Cq values were converted to relative expressions with normalization to MIR2911. The Mann-Whitney U test was performed subsequent to the Kruskal-Wallis test to compare the differences among groups. n, number of patients in the subgroups. #p < 0.017 between SAP and non-SAP patients; $p < 0.017 between SAP and HC; * p < 0.017 between non-SAP and HC

Back to article page